- Home
- ORGO vs RFI Comparison
ORGO vs RFI Comparison
Compare ORGO & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- RFI
- Stock Information
- Founded
- ORGO 1985
- RFI 1992
- Country
- ORGO United States
- RFI United States
- Employees
- ORGO N/A
- RFI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- ORGO Health Care
- RFI Finance
- Exchange
- ORGO Nasdaq
- RFI Nasdaq
- Market Cap
- ORGO 384.4M
- RFI 323.2M
- IPO Year
- ORGO N/A
- RFI N/A
- Fundamental
- Price
- ORGO $3.46
- RFI $12.06
- Analyst Decision
- ORGO Buy
- RFI
- Analyst Count
- ORGO 2
- RFI 0
- Target Price
- ORGO $5.50
- RFI N/A
- AVG Volume (30 Days)
- ORGO 911.8K
- RFI 69.8K
- Earning Date
- ORGO 08-07-2025
- RFI 01-01-0001
- Dividend Yield
- ORGO N/A
- RFI 8.25%
- EPS Growth
- ORGO N/A
- RFI N/A
- EPS
- ORGO N/A
- RFI N/A
- Revenue
- ORGO $458,760,000.00
- RFI N/A
- Revenue This Year
- ORGO $2.62
- RFI N/A
- Revenue Next Year
- ORGO $12.46
- RFI N/A
- P/E Ratio
- ORGO N/A
- RFI N/A
- Revenue Growth
- ORGO 5.35
- RFI N/A
- 52 Week Low
- ORGO $2.28
- RFI $9.62
- 52 Week High
- ORGO $6.71
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- RFI 54.20
- Support Level
- ORGO $3.13
- RFI $11.79
- Resistance Level
- ORGO $3.36
- RFI $12.07
- Average True Range (ATR)
- ORGO 0.21
- RFI 0.14
- MACD
- ORGO 0.08
- RFI -0.01
- Stochastic Oscillator
- ORGO 74.36
- RFI 74.17
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.